Congenital hypothyroidism - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Congenital Hypothyroidism – Comprehensive Guide

Congenital Hypothyroidism – A Complete Patient Guide

Overview

Congenital hypothyroidism (CH) is a condition in which the thyroid gland is under‑active (hypothyroid) from birth. The thyroid hormone (primarily thyroxine/T4 and triiodothyronine/T3) is essential for brain development, growth, and metabolism. When a newborn does not produce enough of these hormones, neurodevelopmental delays and growth failure can occur if the condition is not treated promptly.

  • Who it affects: All newborns are at risk, but the condition is most often identified in infants during routine newborn screening.
  • Prevalence: Approximately 1 in 2,000 to 1 in 4,000 live births worldwide (CDC, 2023). The incidence varies by geographic region and ethnicity; higher rates are reported in Asian populations.
  • Types:
    • Primary CH – the thyroid gland itself is absent, ectopic, or structurally abnormal.
    • Secondary (central) CH – a problem with the pituitary or hypothalamus that fails to stimulate the thyroid.

Symptoms

Most infants with CH are asymptomatic at birth because maternal thyroid hormone crosses the placenta. Symptoms usually appear within the first few weeks to months of life:

General signs in infants

  • Prolonged jaundice – yellowing of the skin that lasts beyond the first two weeks.
  • Large fontanelles – soft spots on the skull that remain open longer than normal.
  • Swollen tongue (macroglossia) – often visible when the infant cries.
  • Dry, coarse skin – may appear pale or mottled.
  • Hoarse cry – a deeper or raspier sound than typical newborn cries.
  • Constipation – poor bowel movements despite feeding.
  • Feeding difficulties – poor suck or weak suck‑reflex.
  • Lethargy or poor responsiveness – infant may seem unusually sleepy.
  • Hypotonia – reduced muscle tone, leading to "floppy" limbs.

Signs that appear after the first few months

  • Growth failure or poor weight gain.
  • Delayed milestones (rolling over, sitting, crawling).
  • Enlarged abdomen (due to constipation or ascites).
  • Developmental delay or intellectual disability if untreated.
  • Hearing loss (sensorineural) – reported in up to 10% of untreated cases.

Causes and Risk Factors

Congenital hypothyroidism is usually caused by a problem with the thyroid gland’s development or function. The most common categories are:

Developmental (Dysgenetic) Causes

  • Ectopic thyroid tissue – the gland is located in the tongue or elsewhere in the neck.
  • Agenesis – complete absence of the thyroid.
  • Hypoplasia – a gland that is present but too small.

Dyshormonogenesis

Genetic defects in enzymes required to synthesize thyroid hormone (e.g., TPO, thyroglobulin, sodium‑iodide symporter). These forms are often inherited in an autosomal recessive pattern.

Central (Secondary) Causes

  • Pituitary or hypothalamic abnormalities that reduce TSH production.
  • Genetic syndromes affecting the hypothalamic‑pituitary axis (e.g., Septo‑Optic Dysplasia).

Risk Factors

  • Family history of CH or dyshormonogenesis.
  • Maternal iodine deficiency or excess (iodine is essential for thyroid hormone production).
  • Maternal exposure to antithyroid drugs (propylthiouracil, methimazole) during pregnancy.
  • Maternal autoimmune thyroid disease (e.g., Hashimoto thyroiditis) – can increase risk of antibody‑mediated fetal thyroid dysfunction.
  • Prematurity (born before 37 weeks) – higher prevalence of transient hypothyroidism.

Diagnosis

Early detection is critical. In most high‑income countries, CH is identified through universal newborn screening.

Screening Test

  • Heel‑stick blood sample collected 24–72 hours after birth.
  • Two primary markers:
    • TSH (thyroid‑stimulating hormone) – elevated in primary CH.
    • T4 (thyroxine) – low or borderline in primary CH; low in central CH.
  • If either marker is abnormal, a repeat specimen or confirmatory serum test is performed.

Confirmatory Tests

  • Serum TSH and Free T4 – definitive values.
  • Thyroid ultrasound – evaluates gland size and location.
  • Radionuclide (Scintigraphy) scan – delineates ectopic tissue (used when ultrasound is inconclusive).
  • Genetic testing – considered for suspected dyshormonogenesis or familial cases.

Diagnostic Criteria (per American Academy of Pediatrics)

  • Serum TSH > 20 µIU/mL or Free T4 < 0.9 ng/dL in the newborn period.
  • For central CH: TSH < 10 µIU/mL with low Free T4.

Treatment Options

Prompt hormone replacement prevents irreversible neurodevelopmental damage. Treatment is simple, inexpensive, and lifelong.

Medications

  • Levothyroxine (LT4) – synthetic T4, the drug of choice. Initial dose: 10‑15 µg/kg/day (sometimes up to 15‑20 µg/kg/day for severe cases).
  • Tablet form is crushed and mixed with breast milk, formula, or a small amount of water for infants who cannot swallow pills.
  • Dosage is adjusted based on serial TSH and Free T4 levels, typically at 2‑week intervals for the first 2‑3 months, then every 1–3 months thereafter.

Monitoring Schedule

AgeFrequency of LabsTarget Levels
0‑3 monthsEvery 2 weeksTSH 0.5‑4 µIU/mL; Free T4 in upper‑normal range
3‑12 monthsEvery 1‑2 monthsSame as above
1‑3 yearsEvery 3‑6 monthsTSH 0.5‑3 µIU/mL
School‑age & beyondEvery 6‑12 monthsTSH 0.5‑3 µIU/mL

Adjunctive Measures

  • Ensure adequate iodine intake (e.g., iodine‑fortified salt) – not excessive, as both deficiency and excess can impair thyroid function.
  • Monitor growth parameters (weight, length/height, head circumference) at routine well‑child visits.
  • Developmental screening (e.g., Ages & Stages Questionnaire) to catch any delays early.

Procedures

Surgery is rarely needed because the problem is hormonal, not mechanical. However, in rare cases of a large ectopic thyroid causing airway obstruction, surgical removal may be considered.

Living with Congenital Hypothyroidism

With appropriate treatment, children with CH lead normal, healthy lives. Below are practical tips for families.

Daily Management

  • Medication adherence – give levothyroxine on an empty stomach, ideally 30 minutes before feeding. Set a daily alarm.
  • Medication storage – keep tablets at room temperature, away from moisture and heat.
  • Track doses in a medication log or mobile app.
  • Bring a copy of the diagnosis and medication list to school or daycare.

Nutrition

  • Breast‑fed infants receive adequate iodine from maternal milk, provided the mother’s diet includes iodine‑rich foods (dairy, seafood, iodized salt).
  • For formula‑fed infants, use iodine‑fortified formula.
  • From age 6 months onward, introduce iodine‑containing foods (e.g., yogurt, cheese, eggs, fish) in age‑appropriate portions.

Growth & Development Monitoring

  • Record weight, length/height, and head circumference at each pediatric visit.
  • Report any slowdown in growth to the endocrinologist promptly.
  • Engage in regular physical activity appropriate for the child’s age.

School & Social Life

  • Most children with CH have normal intelligence when treatment starts within the first 2‑3 weeks of life.
  • Inform teachers of the condition; they may need to know timing of medication administration.
  • Encourage participation in group activities; no restrictions are needed.

Psychosocial Support

  • Connect with parent support groups (e.g., the National Thyroid Association, local online forums).
  • Consider counseling if the child experiences learning difficulties despite adequate hormone levels.

Prevention

Because CH is largely congenital, true primary prevention is limited, but certain measures can reduce risk of *acquired* hypothyroidism in the neonate and improve outcomes.

  • Maternal iodine sufficiency – a daily intake of 150 µg iodine (WHO recommendation) before and during pregnancy.
  • Avoiding unnecessary exposure to antithyroid medications in pregnancy.
  • Screening and treating maternal thyroid disease early to prevent fetal thyroid suppression.
  • Ensuring newborn screening programs are in place and that samples are collected promptly.

Complications

If treatment is delayed or inadequate, serious complications can arise:

  • Severe intellectual disability – historically the hallmark of untreated CH.
  • Growth failure – short stature and delayed puberty.
  • Hearing loss – sensorineural deficits may be irreversible.
  • Neuromuscular problems – hypotonia, poor coordination.
  • Cardiovascular effects – untreated hypothyroidism can lead to bradycardia, pericardial effusion.
  • Myxedema coma (rare in infants but possible in severe, untreated cases) – a medical emergency characterized by hypothermia, hypoglycemia, and altered mental status.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if your child shows any of the following signs:
  • Sudden drop in temperature (hypothermia) – skin feels cold to the touch.
  • Severe lethargy or unresponsiveness.
  • Rapid, shallow breathing accompanied by a slow heart rate (bradycardia).
  • Extreme constipation with abdominal distention.
  • Seizures or convulsions.
  • Persistent vomiting that prevents the child from keeping medication down.

These symptoms may indicate a thyroid storm, myxedema coma, or another acute metabolic crisis. Prompt treatment can be lifesaving.

**References**

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References